Insider Trading March 5, 2026

Skyward Specialty Director Increases Stake With $239,464 of Open-Market Buys

Director Anthony J. Kuczinski added 5,000 shares across three trades, bringing his direct holdings to 11,903 shares amid upbeat quarterly results and valuation commentary

By Ajmal Hussain SKWD
Skyward Specialty Director Increases Stake With $239,464 of Open-Market Buys
SKWD

Anthony J. Kuczinski, a director at Skyward Specialty Insurance Group (NASDAQ: SKWD), purchased common stock in three open-market transactions totaling $239,464. The buys were executed between February 27 and March 3, 2026, and increase his direct ownership to 11,903 shares. The moves come as the stock trades near $48.65 and amid InvestingPro commentary that the shares appear undervalued relative to Fair Value. Skyward also posted stronger-than-expected fourth-quarter 2025 results and disclosed new executive employment agreements for several senior leaders.

Key Points

  • Director Anthony J. Kuczinski purchased a total of 5,000 Skyward Specialty shares across three open-market transactions, spending $239,464.
  • Following the buys, Kuczinski directly owns 11,903 shares; transactions occurred on Feb. 27, Mar. 2 and Mar. 3, 2026 at the prices disclosed.
  • Skyward reported a strong fourth-quarter 2025 with EPS of $1.17 versus an expected $0.77 and revenue of $385.58 million versus $308.67 million expected; the company also announced new executive employment agreements.

Overview

Skyward Specialty Insurance Group (NASDAQ: SKWD) saw a director add to his personal stake this week. Anthony J. Kuczinski completed three open-market purchases of the company's common stock totaling $239,464, with transactions executed on February 27, March 2 and March 3, 2026. The purchases raise Kuczinski's direct holdings to 11,903 shares.

Transaction details

  • February 27, 2026 - 2,000 shares purchased at $46.8751 per share.
  • March 2, 2026 - 2,000 shares purchased at $48.7911 per share.
  • March 3, 2026 - 1,000 shares purchased at $48.1321 per share.

The cumulative value of these open-market buys equals $239,464. Following the trades, Kuczinski holds 11,903 shares of Skyward Specialty directly.

Market context

At the time of these filings, Skyward's stock was trading at $48.65. Analysis from InvestingPro cited in disclosures indicates the company is trading below its calculated Fair Value and highlighted recent price momentum - the stock delivered an 8.11% return over the prior week. InvestingPro also reported a trailing price-to-earnings ratio of 11.85 for the shares and referenced additional paid tips and analysis available to subscribers.

Recent company financials and executive updates

Skyward Specialty reported fourth-quarter 2025 results that outpaced consensus expectations. The company recorded earnings per share of $1.17 versus the expected $0.77, a reported surprise of 51.95%. Revenue for the quarter reached $385.58 million, ahead of the anticipated $308.67 million.

In related filings and a company press release, Skyward disclosed new executive employment agreements for key leaders, including the chief executive officer, Andrew Robinson, and the president of U.S. Property and Casualty, John Burkhart. The agreements outline components such as annual base salary, target bonus opportunities and long-term equity awards. The company noted these awards and compensation terms remain subject to annual board review.

What the transactions indicate

The purchases were carried out on the open market and represent a director increasing his direct position. The filings document the precise trade dates, share counts and per-share prices reported above. Beyond those concrete items, public disclosures attached to the transactions include the InvestingPro valuation commentary and the recent financial and governance updates described earlier.

Takeaway

Investors and market watchers will find the filings useful for tracking insider activity and recent company performance. The transactions, the valuation note from InvestingPro and the company's stronger-than-expected quarterly results and executive compensation disclosures are the facts reflected in the public record.


Note: The article reflects information disclosed in company filings, a press release, and InvestingPro commentary as reported in public disclosures.

Risks

  • Insider purchases do not guarantee future stock performance - market and business risks for the insurance sector could affect returns.
  • Valuation commentary from InvestingPro is an assessment and may differ from other analyses or future market pricing.
  • Executive compensation arrangements are subject to annual board review and may change, introducing potential governance or alignment uncertainty.

More from Insider Trading

Progressive Accounting Chief Disposes $55K in Stock as Shares Trade Near Yearly Low Mar 23, 2026 Old Second Bancorp Vice Chairman Disposes $429K in Shares; Ownership Stakes and Recent Results Also Detailed Mar 23, 2026 Vicor Chairman Disposes $7.9 Million in Stock; Transaction Executed Under 10b5-1 Plan Mar 23, 2026 Nutex Health President Buys $23,706 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026 Nutex Health Director Buys $14,033 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026